Seevix

Jerusalem, Israel Founded: 2014 • Age: 12 yrs
Genetically engineered spider silk fibers are produced for industrial uses.
Annual revenue - Latest available
Total funding - 2 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products 3 Services tracked
Competitors 11 Brand Intelligence

About Seevix

Seevix is a company based in Jerusalem (Israel) founded in 2014. Seevix offers products and services including SVX, SpheroSeev, and HydroSeev. Seevix operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.

  • Headquarter Jerusalem, Israel
  • Sectors
    Healthcare
    Chemicals & Materials
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Chemicals & Materials → Advanced & Functional Materials
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Seevix

Seevix offers a comprehensive portfolio of products and services, including SVX, SpheroSeev, and HydroSeev.

Primary

Biopolymer inspired by spidersilk to enhance product strength and sustainability.

Tool for improving 3D cell culture applications in biotechnology.

System that enhances 3D cell culture for medical and research uses.

People of Seevix

Headcount 10-50
Employee Profiles 5
Employee Profiles
People
Shlomzion S.
Co-founder and CEO
People
Shmulik Ittah
Co-founder and scientific advisor
People
Kosta Press
VP Product Development

Unlock access to complete

Funding Insights of Seevix

  • Total Funding
  • Total Rounds 2
  • Last Round
  • First Round

    (01 Mar 2018)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2020 Amount Seed - Seevix Valuation ASICS Corporation
Mar, 2018 Amount Grant - Seevix Valuation

investors

Investors in Seevix

Seevix has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and ASICS Corporation.

All
Institutional
Investor Description Founded Year Domain Location
Brand of sportswear
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location

Investments & Acquisitions by Seevix

Investments

Financial Statements - Seevix

Seevix Comparisons

+
Add Comparison
Available on Premium

Competitors of Seevix

Seevix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of pharmaceuticals and vaccines for various therapeutic areas
domain founded_year HQ Location
Antibody-siRNA complexes are developed for cancer treatment.
domain founded_year HQ Location
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
domain founded_year HQ Location
Yeast cells are genetically engineered to produce medicinal products.
domain founded_year HQ Location
Developing novel drugs based on a proteome-wide ligand and target discovery platform
domain founded_year HQ Location
CRISPR-engineered cell and gene therapies are developed for research applications.

Latest news on Seevix

Frequently Asked Questions about Seevix

Seevix was founded in 2014 and raised its 1st funding round 4 years after it was founded.

Seevix is headquartered in Jerusalem, Israel. It is registered at Jerusalem, Jerusalem District, Israel.

Seevix was established in 2014 in Jerusalem, Israel, within the biotechnology and materials sector. Patented genetic engineering techniques are applied to create spider silk fibers that match natural counterparts. These fibers function as substitutes for Kevlar and steel in high-tensile roles. A proprietary one-step manufacturing process is utilized for scalable production, which shortens timelines and lowers expenses. Operations focus on supplying materials to diverse industries.

Seevix's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.

Seevix offers SVX, SpheroSeev, and HydroSeev.

Seevix has 2 investors. Key investors include European Union, and ASICS Corporation.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available